MKRN2OS
gene geneOn this page
Summary
MKRN2OS (MKRN2 opposite strand, HGNC:40375) is a protein-coding gene on chromosome 3p25.2, encoding MKRN2 opposite strand protein (H3BPM6).
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 63 total
- MANE Select transcript:
NM_001195279
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:40375 |
| Approved symbol | MKRN2OS |
| Name | MKRN2 opposite strand |
| Location | 3p25.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000225526 |
| Ensembl biotype | protein_coding |
| Entrez | 100129480 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding_CDS_not_defined, 2 protein_coding, 1 nonsense_mediated_decay
ENST00000447550, ENST00000561645, ENST00000564146, ENST00000567514, ENST00000678164, ENST00000896064
RefSeq mRNA: 4 — MANE Select: NM_001195279
NM_001195279, NM_001378009, NM_001378010, NM_001378011
CCDS: CCDS58816
Canonical transcript exons
ENST00000564146 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002587189 | 12545247 | 12545499 |
| ENSE00003516405 | 12541860 | 12542022 |
| ENSE00003592261 | 12543180 | 12543229 |
| ENSE00003639896 | 12539776 | 12540433 |
Expression profiles
Bgee: expression breadth ubiquitous, 131 present calls, max score 85.49.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0367 / max 13.1079, expressed in 15 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 41128 | 0.0367 | 15 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellum | UBERON:0002037 | 85.49 | gold quality |
| cerebellar cortex | UBERON:0002129 | 85.38 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 85.37 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 84.80 | gold quality |
| duodenum | UBERON:0002114 | 79.47 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 78.50 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 77.17 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.55 | silver quality |
| rectum | UBERON:0001052 | 75.33 | gold quality |
| esophagus mucosa | UBERON:0002469 | 75.24 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 75.19 | gold quality |
| body of pancreas | UBERON:0001150 | 74.22 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 74.05 | gold quality |
| minor salivary gland | UBERON:0001830 | 73.50 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 73.29 | gold quality |
| pancreas | UBERON:0001264 | 72.75 | gold quality |
| islet of Langerhans | UBERON:0000006 | 72.12 | gold quality |
| transverse colon | UBERON:0001157 | 70.95 | gold quality |
| small intestine | UBERON:0002108 | 70.61 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 70.59 | gold quality |
| prefrontal cortex | UBERON:0000451 | 70.13 | gold quality |
| apex of heart | UBERON:0002098 | 69.31 | gold quality |
| frontal cortex | UBERON:0001870 | 69.29 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 69.18 | gold quality |
| body of stomach | UBERON:0001161 | 69.15 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 68.74 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 68.19 | gold quality |
| esophagus | UBERON:0001043 | 68.14 | gold quality |
| skin of leg | UBERON:0001511 | 68.05 | gold quality |
| stomach | UBERON:0000945 | 68.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.81 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
12 targeting MKRN2OS, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-5700 | 99.64 | 69.88 | 2280 |
| HSA-MIR-504-3P | 99.30 | 67.18 | 1745 |
| HSA-MIR-6504-3P | 99.17 | 69.31 | 2891 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
| HSA-MIR-140-3P | 99.04 | 67.69 | 1324 |
| HSA-MIR-5089-5P | 98.45 | 66.06 | 1388 |
| HSA-MIR-1278 | 97.75 | 67.55 | 628 |
| HSA-MIR-3920 | 97.75 | 69.02 | 1168 |
| HSA-MIR-552-3P | 96.68 | 64.12 | 1026 |
| HSA-MIR-4259 | 95.68 | 65.25 | 582 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mkrn2os.2 | ENSDARG00000100728 |
| mus_musculus | Mkrn2os | ENSMUSG00000068011 |
| rattus_norvegicus | Mkrn2os | ENSRNOG00000070957 |
Protein
Protein identifiers
MKRN2 opposite strand protein — H3BPM6 (reviewed: H3BPM6)
Alternative names: MKRN2 antisense RNA 1, MKRN2 antisense gene protein 1
All UniProt accessions (2): H3BPM6, H3BSJ0
RefSeq proteins (4): NP_001182208, NP_001364938, NP_001364939, NP_001364940 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032016 | MKRN2OS-like | Family |
| IPR053921 | MKRN2OS-like_C | Domain |
| IPR053922 | MKRN2OS-like_N | Domain |
Pfam: PF16044, PF22795
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-H3BPM6-F1 | 90.36 | 0.81 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 12 (showing top):
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A, HMGA1_TARGET_GENES, LHX9_TARGET_GENES, ZFP3_TARGET_GENES, ZNF33A_TARGET_GENES, MIR1278, DESCARTES_MAIN_FETAL_CSH1_CSH2_POSITIVE_CELLS, CUX1_TARGET_GENES, MEF2C_TARGET_GENES, HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL, GENES_CORRELATED_WITH_RAB35_DELETION, chr3p25
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
46 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MKRN2OS | ANKMY1 | Q9P2S6 | 621 |
| MKRN2OS | MARF1 | Q9Y4F3 | 479 |
| MKRN2OS | DYRK3 | O43781 | 400 |
| MKRN2OS | UBR1 | Q8IWV7 | 368 |
| MKRN2OS | SNAPC2 | Q13487 | 351 |
| MKRN2OS | DDR1 | Q08345 | 333 |
| MKRN2OS | SNAPC4 | Q5SXM2 | 308 |
| MKRN2OS | UPP2 | O95045 | 244 |
| MKRN2OS | ACY1 | Q03154 | 222 |
| MKRN2OS | NAGA | P17050 | 208 |
| MKRN2OS | UPP1 | Q16831 | 205 |
| MKRN2OS | RNGTT | O60942 | 201 |
| MKRN2OS | RNF146 | Q9NTX7 | 194 |
| MKRN2OS | SLC28A2 | O43868 | 189 |
| MKRN2OS | AURKA | O14965 | 187 |
IntAct
0 interactions, top by confidence:
BioGRID (1): MKRN2OS (Affinity Capture-RNA)
ESM2 similar proteins: A4GT88, A7MBC2, A7YD35, F1Q7Z7, F1S5L4, H3BPM6, O15111, O42412, O88351, O95822, P09543, P13233, P16330, P24389, P27229, P27555, P49894, P49895, P49896, P49898, P49899, P97564, Q02556, Q0VCH3, Q1LYL8, Q32NQ7, Q5F259, Q5GJ77, Q5RFD0, Q5XUN4, Q60680, Q61153, Q61179, Q61586, Q62240, Q66HY8, Q6NVV7, Q6P996, Q6QN11, Q6QN13
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
63 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 55 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1629 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:12519048:A:G | acceptor_gain | 1.0000 |
| 3:12519051:A:AG | acceptor_gain | 1.0000 |
| 3:12519198:G:GG | donor_gain | 1.0000 |
| 3:12529760:A:AG | acceptor_gain | 1.0000 |
| 3:12529761:G:GG | acceptor_gain | 1.0000 |
| 3:12529761:GTT:G | acceptor_gain | 1.0000 |
| 3:12541855:TGTA:T | donor_loss | 1.0000 |
| 3:12541856:GTACC:G | donor_loss | 1.0000 |
| 3:12541857:TACCT:T | donor_loss | 1.0000 |
| 3:12541858:A:AT | donor_loss | 1.0000 |
| 3:12541859:CCTGT:C | donor_loss | 1.0000 |
| 3:12542020:CCC:C | acceptor_gain | 1.0000 |
| 3:12542021:CCC:C | acceptor_gain | 1.0000 |
| 3:12543226:CTCT:C | acceptor_gain | 1.0000 |
| 3:12557174:CAG:C | donor_loss | 1.0000 |
| 3:12557177:G:GA | donor_loss | 1.0000 |
| 3:12557178:T:A | donor_loss | 1.0000 |
| 3:12519047:A:AG | acceptor_gain | 0.9900 |
| 3:12519052:A:G | acceptor_gain | 0.9900 |
| 3:12519054:TTTAG:T | acceptor_loss | 0.9900 |
| 3:12519057:A:AG | acceptor_gain | 0.9900 |
| 3:12519057:AG:A | acceptor_gain | 0.9900 |
| 3:12519057:AGG:A | acceptor_loss | 0.9900 |
| 3:12519058:G:GG | acceptor_gain | 0.9900 |
| 3:12519058:GG:G | acceptor_gain | 0.9900 |
| 3:12519058:GGA:G | acceptor_gain | 0.9900 |
| 3:12519193:TTTAC:T | donor_gain | 0.9900 |
| 3:12519195:TACG:T | donor_loss | 0.9900 |
| 3:12519196:ACG:A | donor_loss | 0.9900 |
| 3:12519197:CGTAA:C | donor_loss | 0.9900 |
AlphaMissense
1475 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:12541912:A:G | W127R | 0.995 |
| 3:12541912:A:T | W127R | 0.995 |
| 3:12541970:C:A | W107C | 0.995 |
| 3:12541970:C:G | W107C | 0.995 |
| 3:12541972:A:G | W107R | 0.995 |
| 3:12541972:A:T | W107R | 0.995 |
| 3:12540335:A:G | F177S | 0.992 |
| 3:12541910:C:A | W127C | 0.992 |
| 3:12541910:C:G | W127C | 0.992 |
| 3:12545280:A:G | F62S | 0.990 |
| 3:12540388:G:C | F159L | 0.989 |
| 3:12540388:G:T | F159L | 0.989 |
| 3:12540390:A:G | F159L | 0.989 |
| 3:12540334:A:C | F177L | 0.988 |
| 3:12540334:A:T | F177L | 0.988 |
| 3:12540336:A:G | F177L | 0.988 |
| 3:12541961:G:C | S110R | 0.988 |
| 3:12541961:G:T | S110R | 0.988 |
| 3:12541963:T:G | S110R | 0.988 |
| 3:12545252:A:C | F71L | 0.988 |
| 3:12545252:A:T | F71L | 0.988 |
| 3:12545254:A:G | F71L | 0.988 |
| 3:12541873:A:G | W140R | 0.987 |
| 3:12541873:A:T | W140R | 0.987 |
| 3:12540389:A:G | F159S | 0.984 |
| 3:12541971:C:G | W107S | 0.984 |
| 3:12543194:A:T | I85K | 0.984 |
| 3:12541911:C:G | W127S | 0.982 |
| 3:12543200:A:T | V83D | 0.981 |
| 3:12543194:A:C | I85R | 0.980 |
dbSNP variants (sampled 300 via entrez): RS1000022363 (3:12548821 C>A,T), RS1000090405 (3:12549036 G>C), RS1000129221 (3:12556747 A>G,T), RS1000143842 (3:12557990 C>G), RS1000368371 (3:12561181 A>G), RS1000574675 (3:12544594 A>G), RS1000739190 (3:12539385 T>C), RS1000771687 (3:12559886 A>G,T), RS1000902823 (3:12543912 A>C), RS1001116200 (3:12554963 C>A,T), RS1001214351 (3:12549573 G>A,C,T), RS1001251906 (3:12555462 T>C), RS1001272821 (3:12543774 C>T), RS1001402846 (3:12544242 G>A), RS1001407755 (3:12548739 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90020025_1924 | Waist-to-hip ratio adjusted for BMI | 2.000000e-10 |
| GCST90020026_186 | Hip index | 2.000000e-12 |
| GCST90020027_154 | Waist-hip index | 2.000000e-11 |
| GCST90020028_705 | Hip circumference adjusted for BMI | 1.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Estradiol | affects cotreatment, decreases expression | 2 |
| licochalcone B | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Particulate Matter | increases expression | 1 |
| Magnetite Nanoparticles | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.